miRNA Delivery by Nanosystems: State of the Art and Perspectives
MicroRNAs (miRNAs) are short (~21–23 nucleotides), non-coding endogenous RNA molecules that modulate gene expression at the post-transcriptional level via the endogenous RNA interference machinery of the cell. They have emerged as potential biopharmaceuticals candidates for the treatment of various...
Saved in:
Main Authors: | Fernanda C. Moraes, Chantal Pichon, Didier Letourneur, Frédéric Chaubet |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/72ce100320b243e6a7fc6d025709bf30 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thinking Quantitatively of RNA-Based Information Transfer via Extracellular Vesicles: Lessons to Learn for the Design of RNA-Loaded EVs
by: Max Piffoux, et al.
Published: (2021) -
Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma
by: Liang C, et al.
Published: (2017) -
IMDAILM: Inferring miRNA-Disease Association by Integrating lncRNA and miRNA Data
by: Yuhua Yao, et al.
Published: (2020) -
The roles of miRNA, lncRNA and circRNA in the development of osteoporosis
by: Yang,Yang, et al.
Published: (2020) -
Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention
by: Pratibha Pandey, et al.
Published: (2021)